https://imahealth.substack.com/p/major-new-study-measles-is-highly?

Major New Study: “Measles Is Highly Treatable” IMA Peer-Reviewed Study Published in Antiviral Research

Comprehensive analysis highlights evidence-based therapeutic strategies and calls for a broader public health conversation about measles.

https://popularrationalism.substack.com/p/whats-really-going-on-in-south-carolinas?

What’s Really Going On in South Carolina’s Measles Outbreak?

Key data points are missing that would allow a rational assessment.

As of early February 2026, South Carolina remains the center of the largest measles outbreak in the U.S. in over 30 years. With 920 confirmed cases and over 90% reportedly occurring in “unvaccinated” individuals, headlines suggest a crisis of vaccine refusal. But beneath the headlines lies a more complex picture—one shaped by data classification, eligibility confusion, and methodological blind spots that public health authorities have failed to address.

This article unpacks the numbers behind the outbreak, highlights structural flaws in case reporting, and shows why surface-level interpretations of vaccination status are no substitute for scientific analysis.  (See link for article)

A few examples of the shamwizardry:

  1. Classification flaws: “Unvaccinated” includes infants under 12 months that are not eligible for MMR, conflating ineligibility with refusal
  2. No Denominators: Vaccine effectiveness (VE) requires knowing how many vaxxed and unvaxxed were at risk, exposed, or susceptible
  3. Misclassification: Those vaxxed who developed a rash within 21 days and were not genotyped via testing may have been declared ‘measles cases’ even though they are not contagious
  4. Confirmation Method not disclosed: measles outbreaks in high-vaxxed settings rely heavily on epi-linkage which means ONE PCR-confirmed case can result in DOZENS of cases being confirmed simply by association – without any testing.
  5. No breakdown of hospitalizations by vax status or age group.  Without cross-tabs, no assessment can be made.
  6. Most moms were vaxxed, not infected and antibody titers passed to babies wane far earlier leaving infants vulnerable the first year. Blaming parents for not vaxxing ignores the change in measles immunity
  7. No public access to raw case data.  What’s up with that?  Without public scrutiny any claims made are assertions not conclusions.
  8. Misapplication of surveillance architecture designed to detect outbreaks not evaluate efficacy.
  9. No audits on time, location, vaccine lot, etc revealing a logistical problem not an immunological problem

New Study Reviews Therapeutic Candidates for Measles

A new peer-reviewed study from IMA researchers reviews therapeutic candidates for measles, including Vitamin A. Why isn’t this part of the conversation?
acute management of measles hero

If you’ve followed the news this year, you might think measles is an unstoppable force. Headlines warn of “surges” and “outbreaks,” case counts are tallied like a scoreboard, and the message is clear: be afraid.

But there’s a part of the story that rarely makes it into the coverage. In developed countries, serious complications from measles are rare. And perhaps most importantly: promising therapeutic candidates exist.

A new peer-reviewed study co-authored by IMA President Dr. Joseph Varon and Director of Research Matthew Halma adds to a growing body of research aimed at exploring therapeutic candidates for measles. Published in Antiviral Research, this systematic review compiles clinical evidence for treatment options—the kind of information that could help patients and physicians make informed decisions. So why isn’t it part of the conversation?

“Adjunctive therapies, including Vitamin A, Ribavirin, and Interferon-α, and emerging antiviral candidates, play an important role in reducing complications… Continued research is urgently needed to validate novel antivirals and immunomodulatory treatments.” — Study authors

📖 Read and Download the Full Paper

Acute management of measles: A systematic review of therapeutic strategies Authors: Amandeep Kaur, Ugo Alaribe, Joseph Varon, Sidra Hassaan and Matthew Halma

(See link for article)

_______________

**Comment**

I love it when people who swallow the red pill decide to act in their sphere of influence.  Be thankful for the COVID train-wreck.  It woke a lot of people up!

Please read the entire article above but it’s worth pointing out a few salient facts:

  • Measles was nearly eradicated before a vaccine was introduced.  Deaths dropped from about 13 to .2 per 100,000.
  • Like any other disease, the outcome depends heavily on pre-existing health.
  • Vitamin A deficiency is a major factor (92% of hospitalized measles patients are deficient)

The following treatment candidates should be considered:

  • Vitamin A
  • Antivirals (Ribavirin and Interferon-a)
  • Supportive therapies (IVIG, antibiotics, vitamin C and D)
  • Investigational therapies (ERDRP-0519 and Monoclonal antibodies)

For more resources on measles, check out these guides from IMA:

For more:

Download the Measles Fact Sheet